Leuconostoc bacteremia in pediatric patients with short bowel syndrome

Pediatric Infectious Disease Journal

Volumn 27, Issue 11, 2008, Pages 1013-1019

  Florescu, Diana ^a,b   Hill, Lisa ^a   Sudan, Debra ^b   Iwen, Peter C ^b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bacteremia; Leuconostoc; Pediatric; Short bowel syndrome

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; GENTAMICIN; IMIPENEM; LINEZOLID; MICAFUNGIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; BACTEREMIA; BACTERIUM DETECTION; BLOOD CULTURE; CHILD; CLINICAL ARTICLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERIC FEEDING; FEMALE; HUMAN; INFANT; INTESTINE MUCOSA; LEUCONOSTOC; LEUCONOSTOC MESENTEROIDES; MALE; NONHUMAN; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SHORT BOWEL SYNDROME; TOTAL PARENTERAL NUTRITION; VASCULAR ACCESS; ANTIBIOTIC RESISTANCE; CASE REPORT; DNA SEQUENCE; DRUG EFFECT; GENETICS; GRAM POSITIVE INFECTION; INDWELLING CATHETER; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; POLYMERASE CHAIN REACTION; REVIEW;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; ENTERAL NUTRITION; FEMALE; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LEUCONOSTOC; MALE; PARENTERAL NUTRITION, TOTAL; PENICILLIN G; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SHORT BOWEL SYNDROME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 58149168894     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181792621     Document Type: Article

References (31)

1. Shlaes DM, Marino J, Jacobs MR. Infection caused by vancomycinresistant Streptococcussanguis II. Antimicrob Agents Chemother. 1984; 25:527-528.
2. Handwerger S, Horowitz H, Coburn K, Kolokathis A, Wormser GP. Infection due to Leuconostocspecies: six cases and review. Rev Infect Dis. 1990;12:602-610.
3. Bernaldo de Quiros JC, Munoz P, Cercenado E, Hernandez Sampelayo T, Moreno S, Bouza E. Leuconostocspecies as a cause of bacteremia: two case reports and a literature review. Eur J Clin Microbiol Infect Dis. 1991;10:505-509.
4. Dhodapkar KM, Henry NK. Leuconostocbacteremia in an infant with short-gut syndrome: case report and literature review. Mayo Clin Proc. 1996;71:1171-1174.
5. Carapetis J, Bishop S, Davis J, Bell B, Hogg G. Leuconostocsepsis in association with continuous enteral feeding: two case reports and a review. Pediatr Infect Dis J. 1994;13:816-823.
6. Scano F, Rossi L, Cattelan A, et al. Leuconostocspecies: a case-cluster hospital infection. Scand J Infect Dis. 1999;31:371-373.
7. Casanova-Roman M, Rios J, Sanchez-Porto A, Gomar JL, Casanova-Bellido M. Leuconostocbacteremia in a healthy infant. Minerva Pediatr. 2003;55:83-86.
8. Coovadia YM, Solwa Z, van den Ende J. Meningitis caused by vancomycin-resistant Leuconostocsp. J Clin Microbiol. 1987;25:1784-1785.
9. Kostman JR, Alden MB, Mair M, Edlind TD, LiPuma JJ, Stull TL. A universal approach to bacterial molecular epidemiology by polymerase chain reaction ribotyping. J Infect Dis. 1995;171:204-208.
10. Rogasa M, Sharpe ME. Species differentiation of human vaginal Lactobacilli. J Gen Microbiol. 1960;23:197-201.
11. Ruoff KL, Kuritzkes DR, Wolfson JS, Ferraro MJ. Vancomycin-resistant gram-positive bacteria isolated from human sources. J Clin Microbiol. 1988;26:2064-2068.
12. Green M, Wadowsky RM, Barbadora K. Recovery of vancomycinresistant gram-positive cocci from children. JClin Microbiol. 1990;28:484-488.
13. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis. 1999;29:490-494.
14. Golan Y, Poutsiaka DD, Tozzi S, Hadley S, Snydman DR. Daptomycin for line-related Leuconostocbacteraemia. J Antimicrob Chemother. 2001;47:364-365.
15. Jofre ML, Sakurada ZA, Ulloa FMT, et al. Leuconostocinfections in patients with short gut syndrome, parenteral nutrition and continuous enteral feeding. Rev Chilena Infectol. 2006;23:340-345.
16. Noriega FR, Kotloff KL, Martin MA, Schwalbe RS. Nosocomial bacteremia caused by Enterobacter sakazakikiand Leuconostoc mesenteroidesresulting from extrinsic contamination of infant formula. Pediatr Infect Dis J. 1990;9:447-449.
17. World Health Organization with Food and Agriculture Organization of the United Nations. Safe preparation, storage and handling of powdered infant formula guidelines. 2007.
18. Hardy S, Ruoff KL, Catlin EA, Ignacio Santos J. Catheter-associated infection with a vancomycin-resistant gram-positive coccus of the Leuconostocsp. Pediatr Infect Dis J. 1988;7:519-520.
19. Edlund C, Barkholt L, Olsson-Liljequist B, Nord CE. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis. 1997;25:729-732.
20. Auge B, Donnio PY, Le Deaut P, Avril JL. Influence of vancomycin by venous route on salivary and fecal aerobic floras. Pathol Biol (Paris). 1987;35:673-675.
21. Buu-Hoi A, Branger C, Acar JF. Vancomycin-resistant Streptococcior Leuconostocsp. Antimicrob Agents Chemother. 1985;28:458-460.
22. Coovadia YM, Solwa Z, van Den Ende J. Potential pathogenicity of Leuconostoc. Lancet. 1988;1:306.
23. Golledge CL. Infection due to Leuconostocspecies. Rev Infect Dis. 1991;13:184-185.
24. Friedland IR, Snipelisky M, Khoosal M. Meningitis in a neonate caused by Leuconostocsp. JClin Microbiol. 1990;28:2125-2126.
25. Giraud P, Attal M, Lemouzy J, Huguet F, Schlaifer D, Pris J. Leuconostoc,a potential pathogen in bone marrow transplantation. Lancet. 1993;341:1481-1482.
26. Espinoza R, Kusne S, Pasculle AW, Wada S, Fung J, Rakela J. Leuconostocbacteremia after liver transplantation: another cause of vancomycin resistant gram-positive infection. Clin Transplant. 1997;11: 322-324.
27. Swenson JM, Facklam RR, Thornsberry C. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus,and Lactobacillusspecies. Antimicrob Agents Chemother. 1990;34:543-549.
28. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. CSLI Document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
29. Handwerger S, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis. 1985;7:368-386.
30. Isenberg HD, Vellozzi EM, Shapiro J, Rubin LG. Clinical laboratory challenges in the recognition of Leuconostocspp. J Clin Microbiol. 1988;26:479-483.
31. de la Maza L, Ruoff KL, Ferraro MJ. In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria. Antimicrob Agents Chemother. 1989;33:1383-1384.